Biomarker ID | 569 |
PMID | 21088161 |
Year | 2010 |
Biomarker | D-Dimer |
Biomarker Basis | Expression Based |
Biomolecule | Protein |
Source | Blood |
Subjects | Humans |
Regulation | Upregulated in Progressive Disease |
Odds Ratio/Hazard Ratio/Relative Risk | OR: 12.07 |
Effect on Pathways | NA |
Experiment | progressive disease (PD) Vs nonprogressive disease (non-PD) |
Type of Biomarker | Prognostic |
Cohort | 28 patients with refractory castration-resistant prostate cancer |
Senstivity | NA |
Specificity | NA |
AUC | NA |
Accuracy | NA |
Level Of Significance | p<0.024 |
Method Used | ELISA |
Clinical | No |
Remarks | The paper compared PSA, CTC and D-dimers are biomarkers for progressive disease, D-dimers were a more significant predictor of progressive disease. |
Clinical Trial Number | NA |
Degree Of Validity | Not validated on independent patient dataset |
Technical Name | NA |